| Heading: |
Attention Deficit Hyperactivity Disorder: Drugs |
| Question ID: |
1745578 |
| UIN: |
16751 |
| House: |
Commons |
| Date tabled: |
2024-11-28 |
| Asking Member ID: |
4126 |
| Asking Member display name: |
Mary Glindon
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Mary Glindon
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, pursuant to the Answer to Question 12405 of 13 November 2024, whether he has had discussions with the community pharmacy sector on improving real-time communication on the availability of ADHD medi |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-04 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
No discussions have been held. The Department has worked with specialist clinicians, including those within the National Health Service, to develop management advice for the NHS. The guidance signposts all sectors to refer to the Specialist Pharmacy Servi... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |